Press Releases

Date Title and Summary Additional Formats
Toggle Summary Medidata Offers Breakthrough to De-Risk Clinical Trial Submissions
Medidata Edge Trial Assurance uses AI to find data quality issues and helps resolve them before submission to the FDA NEW YORK --(BUSINESS WIRE)--May 8, 2018-- To help organizations mitigate the risk of regulatory non-approval and delays, Medidata Solutions (NASDAQ:MDSO) is transforming how
Toggle Summary Medidata’s Melinda Pautsch Named a “Rising Star” by the Healthcare Businesswomen’s Association
NEW YORK --(BUSINESS WIRE)--May 3, 2018-- Medidata (NASDAQ: MDSO) is pleased to announce that its director of strategic accounts and medical device/diagnostic sales, Melinda Pautsch , has been named a 2018 “Rising Star” by the Healthcare Businesswomen’s Association (HBA).
Toggle Summary Medidata to Present at Jefferies 2018 Global Technology Conference
NEW YORK --(BUSINESS WIRE)--May 2, 2018-- Medidata (NASDAQ: MDSO) today announced that Rouven Bergmann , chief financial officer, will present at the Jefferies 2018 Global Technology Conference on Wednesday, May 9, 2018 , at 2:30 p.m. PT ( 5:30 p.m. ET ) in Beverly Hills, Calif.
Toggle Summary Idera Pharmaceuticals Increases Operational Efficiency of Global Oncology Program with Medidata Clinical Cloud
Medidata’s Solutions to Accelerate Studies, Improve Data Quality, and Drive Greater Patient Enrollment NEW YORK --(BUSINESS WIRE)--May 1, 2018-- Medidata (NASDAQ:MDSO) today announced that Idera Pharmaceuticals, Inc . (NASDAQ:IDRA), expanded its use of the Medidata Clinical Cloud® to automate
Toggle Summary Medidata Edge Strategic Monitoring Wins “Best Sponsor-Focused Technological Development” at CARE Awards 2018
Company Celebrates Third Consecutive Informa CARE Award Win NEW YORK --(BUSINESS WIRE)--Apr. 27, 2018-- Medidata (NASDAQ: MDSO) is pleased to announce that its risk based monitoring solution, Edge Strategic Monitoring , won an Informa Clinical and Research Excellence ( CARE ) Award, marking the
Toggle Summary Life Science Leaders Discuss Future of Drug Development at Medidata NEXT London
Novartis to present on digital transformation in clinical research LONDON --(BUSINESS WIRE)--Apr. 24, 2018-- Medidata (NASDAQ: MDSO) is hosting the final European NEXT conference in London this week, with executives presenting from Novartis , aparito, and the global life sciences community.
Toggle Summary Medidata Reports First Quarter 2018 Results
Total revenue of $149.2 million , representing 17% year-over-year growth GAAP operating margin of 8.9%; non-GAAP operating margin of 22.9%, representing 120 basis points year-over-year margin expansion Total multi-year subscription backlog, unadjusted for renewals, of $1.0 billion as of March 31,
Toggle Summary Medidata Schedules First Quarter Earnings Conference Call for April 19, 2018
NEW YORK --(BUSINESS WIRE)--Apr. 5, 2018-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its first quarter 2018 financial results before the open of the market on Thursday, April 19, 2018
Toggle Summary Australia NHMRC Clinical Trials Centre Partners with Medidata to Digitize Cancer Research
Leading Australian clinical trials centre adopts Medidata Clinical Cloud ® to accelerate clinical research SYDNEY & NEW YORK --(BUSINESS WIRE)--Apr. 3, 2018-- Medidata (NASDAQ: MDSO) announced that the National Health and Medical Research Council Clinical Trial Centre (NHMRC CTC), University of
Toggle Summary Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives
Where Life Sciences Leaders Meet Transformative Technology Meets the Future LONDON --(BUSINESS WIRE)--Mar. 28, 2018-- Medidata (NASDAQ:MDSO) successfully hosted NEXT conferences in Basel and Frankfurt , with executives from global life sciences and pharmaceutical companies presenting, including

Investor Contact

Betsy Frank
+1 917 522 4620